市场调查报告书
商品编码
1298703
皮下注射针头市场:2023-2028年全球行业趋势、份额、规模、增长、机会和预测Hypodermic Needles Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2023-2028 |
2022年,全球皮下注射针头市场规模达到27亿美元。展望未来,IMARC集团预计,到2028年,市场规模将达到41亿美元,在2023-2028年期间呈现6.9%的增长率(CAGR)。
皮下注射针是指与注射器一起使用的薄而空的针头,用于向体内注射物质。它们还协助从体内提取液体,如在静脉穿刺中从静脉中提取血样。它们通常使用不锈钢管通过拔管工艺制造。皮下注射针还可用于提供不能口服的药物,因为这些药物不容易被吸收(如胰岛素)或可能伤害病人的肝脏。此外,它们有一个极其光滑和锋利的表面,在接种无菌基质时可以防止和减少污染。因此,皮下注射针在需要无菌条件的医疗部门和研究环境中得到了广泛的应用。
皮下注射针被医务人员、医生、牙医和护理人员广泛用于紧急情况下的快速皮内输液、疫苗接种、药物管理和血样采集,这是推动市场增长的主要因素。此外,感染和慢性病的广泛流行,如癌症、糖尿病和心血管疾病,使疫苗和注射药物的需求升级。与此同时,为遏制冠状病毒病(COVID-19)在全球范围内的传播而正在进行的疫苗接种活动,也催化了对皮下注射针头的需求。除此之外,各国政府实施严格的法规,规定使用安全针头,以防止针头重复使用,减少感染的风险,这也推动了市场的增长。此外,一些领先的制造商正在开发精密工程的皮下注射针头,以提高病人在肠外治疗中的舒适度,并减少穿刺阻力。他们还在检查和测试过程中对自动化系统进行大量投资,以满足质量标准并确保安全用药。其他因素,包括防止针刺伤害的需求不断增长,血液传播疾病病例激增,献血量增加,医疗保健基础设施改善,以及技术进步,也在创造一个有利的市场前景。
The global hypodermic needles market size reached US$ 2.7 Billion in 2022. Looking forward, IMARC Group expects the market to reach US$ 4.1 Billion by 2028, exhibiting a growth rate (CAGR) of 6.9% during 2023-2028.
Hypodermic needles refer to thin, hollow needles used with a syringe to inject substances into the body. They also assist in extracting fluids from the body, such as taking a blood sample from a vein in venipuncture. They are typically manufactured using stainless-steel tubes through the tube drawing process. Hypodermic needles can also be utilized to provide medications that cannot be ingested orally because they cannot be absorbed easily (like insulin) or potentially harm the patient's liver. Moreover, they have an extremely smooth and sharp surface which prevents and minimizes contamination during inoculation of a sterile substrate. As a result, hypodermic needles find extensive applications in the healthcare sector and research environments requiring sterile conditions.
Hypodermic needles are widely used by medical professionals, physicians, dentists, and paramedics for rapid intradermal delivery of liquids in case of emergencies, vaccination, administration of drugs, and blood sample collection, which represents the primary factor driving the market growth. Additionally, the widespread prevalence of infections and chronic diseases, such as cancer, diabetes, and cardiovascular disorders, has escalated the demand for vaccines and injectable drugs. Along with this, the ongoing vaccination campaigns to curb the spread of coronavirus disease (COVID-19) across the globe are catalyzing the demand for hypodermic needles. Besides this, the implementation of stringent regulations by governments of various countries that mandate the use of safety needles to prevent needle re-usage and mitigate the risk of infections is propelling the market growth. Furthermore, several leading manufacturers are developing precision-engineered hypodermic needles to enhance patient comfort in parenteral therapies and reduce penetration resistance. They are also making heavy investments in automated systems for inspection and testing processes to meet the quality standards and ensure the safe administration of medications. Other factors, including the growing need to prevent needle-stick injuries, surging cases of blood-borne diseases, increasing blood donations, improving healthcare infrastructure, and technological advancements, are also creating a favorable market outlook.
IMARC Group provides an analysis of the key trends in each sub-segment of the global hypodermic needles market report, along with forecasts at the global, regional and country level from 2023-2028. Our report has categorized the market based on product type, application and end user.
Safety Hypodermic Needles
Non-Safety Hypodermic Needles
Drug Delivery
Vaccination
Blood Specimen Collection
Hospitals and Clinics
Ambulatory Surgical Centers
Diabetic Patients
Family Practices
Psychiatrics
Others
North America
United States
Canada
Asia-Pacific
China
Japan
India
South Korea
Australia
Indonesia
Others
Europe
Germany
France
United Kingdom
Italy
Spain
Russia
Others
Latin America
Brazil
Mexico
Others
Middle East and Africa
The competitive landscape of the industry has also been examined along with the profiles of the key players being B. Braun Melsungen AG, Becton Dickinson and Company, Cardinal Health Inc., Connecticut Hypodermics Inc., EXELINT International Co., Hi-Tech Syringes, McKesson Corporation, Medline Industries LP, Nipro Corporation, Retractable Technologies Inc., Smiths Medical Inc. (ICU Medical Inc.) and Terumo Corporation.